The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants—Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.70072 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Megan Heath und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sanofi, Reading, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Drugs, Investigational, Clinical Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Decentralized clinical trials (DCTs), which move trial activities to participants’ homes or direct surroundings, offer potential advantages over conventional site‐based trials through reduced participant burden and improved accessibility. The direct‐to‐participant (DtP) delivery of investigational medicinal products (IMPs) and other study materials and collection of biological samples requires careful planning and execution to ensure participant safety and data integrity. Here, we report operational experiences from the RADIAL proof‐of‐concept trial, a three‐arm parallel‐group study conducted across six European countries comparing conventional, hybrid, and fully decentralized approaches in type 2 diabetes patients. The study implemented two DtP IMP models: clinical trial site‐to‐participant and central pharmacy‐to‐participant delivery, with comprehensive logistics tracking and temperature monitoring. In RADIAL, 68 DtP IMP shipments were executed with a 94% successful delivery rate. Four shipments (6%) failed due to participant unavailability, temperature excursions, defective monitoring equipment, or courier loss. The central pharmacy model demonstrated inventory savings compared with conventional site‐based distribution. Biological sample collection for HbA1c assessment was done through drop‐off, which proved more challenging in the remote arm. Key challenges related to DCT logistics as experienced in RADIAL included unclear importer/exporter responsibilities, regulatory divergence across countries, participant material management, and sample drop‐off reliability. DtP IMP delivery and biological sample collection are feasible in European DCTs but require enhanced planning, clear vendor responsibilities, and robust contingency procedures. Success depends on appropriate participant training, reliable courier services, temperature control systems, and accessible biological sample collection methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanofi, Reading, UK.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
- Sanofi, Beijing, China.
- Julius Clinical, Zeist, Netherlands.
- Sanofi, Paris, France.
- Sanofi, Berlin, Germany.
ORCID-Profile: Megan Heath, Amos J de Jong, Danny R van Weelij, Yvonne van Rijswick, Bart Lagerwaard, Mira G P Zuidgeest
Zitieren
APA
Heath, M., de Jong, A. J., Magorrian-Spence, S., Jin, C., van Weelij, D. R., Pagnier, L., van Rijswick, Y., Haufe, V., Lagerwaard, B., Zuidgeest, M. G. P., & Trials@Home consortium (2025). The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants—Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70072
Vancouver
Heath M, de Jong AJ, Magorrian-Spence S, Jin C, van Weelij DR, Pagnier L, et al. The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants—Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70072
BibTeX
@article{Heath2025,
author = {Heath, Megan and de Jong, Amos J and Magorrian-Spence, Shaun and Jin, Chao and van Weelij, Danny R and Pagnier, Lucas and van Rijswick, Yvonne and Haufe, Volker and Lagerwaard, Bart and Zuidgeest, Mira G P and Trials@Home consortium, Trials@Home consortium},
title = {The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants—Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.70072}
}
EUVIMED